Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years

被引：0
|
作者：
Lisi M. Dredze
Michael Friger
Samuel Ariad
Michael Koretz
Bertha Delgado
Ruthy Shaco-Levy
Margarita Tokar
Michael Bayme
Ravit Agassi
Maia Rosenthal
Victor Dyomin
Olga Belochitski
Shai Libson
Tamar Mizrahi
David B. Geffen
机构：
[1] Ben-Gurion University of the Negev,Faculty of Health Sciences
[2] Soroka University Medical Center,Department of Oncology
[3] Ben-Gurion University of the Negev,Department of Public Health
[4] Soroka Medical Center,Division of Surgery and The Eshkol Breast Center
[5] Soroka University Medical Center,Department of Pathology
[6] Soroka Medical Center,Department of Imaging and The Eshkol Breast Center
来源：
Breast Cancer Research and Treatment | 2022年 / 193卷
关键词：
Neoadjuvant; Doxorubicin-cyclophosphamide; Paclitaxel; Breast cancer; Real-world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：597 / 612
页数：15
相关论文
共 45 条
  • [41] Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Romond, Edward H.
    Jeong, Jong-Hyeon
    Rastogi, Priya
    Swain, Sandra M.
    Geyer, Charles E., Jr.
    Ewer, Michael S.
    Rathi, Vikas
    Fehrenbacher, Louis
    Brufsky, Adam
    Azar, Catherine A.
    Flynn, Patrick J.
    Zapas, John L.
    Polikoff, Jonathan
    Gross, Howard M.
    Biggs, David D.
    Atkins, James N.
    Tan-Chiu, Elizabeth
    Zheng, Ping
    Yothers, Greg
    Mamounas, Eleftherios P.
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (31) : 3792 - 3799
  • [42] Reply: "Patients treated with neoadjuvant chemotherapy plus radical surgery plus adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-years follow-up"
    Luvero, D.
    Plotti, F.
    Angioli, R.
    MEDICAL ONCOLOGY, 2017, 34 (01)
  • [43] Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY-HEART study)
    Locquet, Medea
    Spoor, Daan
    Crijns, Anne
    van der Harst, Pim
    Eraso, Arantxa
    Guedea, Ferran
    Fiuza, Manuela
    Santos, Susana Constantino Rosa
    Combs, Stephanie
    Borm, Kai
    Mousseaux, Elie
    Gencer, Umit
    Frija, Guy
    Cardis, Elisabeth
    Langendijk, Hans
    Jacob, Sophie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] An exploratory correlative biomarker analysis of NSABP FB-7, a phase II randomized trial evaluating neoadjuvant therapy with weekly paclitaxel (P) plus neratinib (N) or trastuzumab (T) or neratinib and trastuzumab (N plus T) followed by doxorubicin and cyclophosphamide (AC) with postoperative T in women with locally advanced HER2-positive breast cancer
    Gavin, P. G.
    Kim, P. S.
    Lipchick, C.
    Langley, E.
    Feng, H.
    Meyer, G. R.
    Kim, S. Rim
    Michel, J. P.
    Jacobs, S. A.
    Srinivasan, A.
    Pogue-Geile, K. L.
    CANCER RESEARCH, 2017, 77
  • [45] Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients
    Higami, Akane
    Takada, Masahiro
    Kawaguchi-Sakita, Nobuko
    Kawashima, Masahiro
    Kawaguchi, Kosuke
    Yamaguchi, Ayane
    Takeuchi, Yasuhide
    Yamada, Yosuke
    Toi, Masakazu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (11) : 1715 - 1720
12345